Cargando…
Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells
A novel melatonin, estrogen, and progesterone hormone therapy was developed as a safe bio-identical alternative hormone therapy for menopausal women based on the Women’s Health Initiative findings that PremPro™ increased breast cancer risk and mortality of all types of breast cancer in postmenopausa...
Autores principales: | Hasan, Mahmud, Browne, Erin, Guarinoni, Laura, Darveau, Travis, Hilton, Katherine, Witt-Enderby, Paula A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318814/ https://www.ncbi.nlm.nih.gov/pubmed/32636633 http://dx.doi.org/10.1177/1178223420924634 |
Ejemplares similares
-
Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7
por: Alghanem, Bandar, et al.
Publicado: (2020) -
Antitumor Activity of Chinese Propolis in Human Breast Cancer MCF-7 and MDA-MB-231 Cells
por: Xuan, Hongzhuan, et al.
Publicado: (2014) -
Differences in the starvation-induced autophagy response in MDA-MB-231 and MCF-7 breast cancer cells
por: Zhu, Wanyun, et al.
Publicado: (2017) -
Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman
por: Singh, Neetu, et al.
Publicado: (2012) -
Apoptosis Induced by 13-S-hydroxyoctadecadienoic acid in the Breast Cancer Cell Lines, MCF-7 and MDA-MB-231
por: Tavakoli Yaraki, Masoumeh, et al.
Publicado: (2013)